Aurisco Pharmaceutical Co.,Ltd. (SHA:605116)
China
· Delayed Price · Currency is CNY 25.75
+0.23 (0.90%)
At close: Mar 9, 2026
Aurisco Pharmaceutical Market Cap
Aurisco Pharmaceutical has a market cap or net worth of 10.46 billion as of March 9, 2026. Its market cap has increased by 27.09% in one year.
Market Cap
10.46B
Enterprise Value
10.41B
Revenue
1.62B
Ranking
n/a
PE Ratio
24.22
Stock Price
25.75
Market Cap Chart
Since September 21, 2020, Aurisco Pharmaceutical's market cap has increased from 4.83B to 10.46B, an increase of 116.46%. That is a compound annual growth rate of 15.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Sinopep-Allsino Biopharmaceutical | 10.27B |
| Liaoning Chengda Biotechnology | 10.25B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 10.70B |
| HitGen | 10.83B |
| Chengzhi | 10.85B |
| Chongqing Genrix Biopharmaceutical | 9.84B |
| Chengdu Easton Biopharmaceuticals | 9.65B |
| Bio-Thera Solutions | 9.37B |